Ceftibuten is an oral third-generation cephalosporin used for otitis media, pharyngitis and respiratory tract infections, particularly in paediatric practice. Simson Pharma's Ceftibuten reference standard and impurities support compendial testing for this oral paediatric-relevant antibiotic.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Ceftibuten Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.